author-photo

Jeffrey A. Bubis

Dartmouth College

7

Papers

30

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Trimodality therapy for stage II-III carcinoma of the esophagus: A dose-ranging study of concurrent capecitabine, docetaxel, and thoracic radiotherapy.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Chemotherapeutic Treatment Issues in the Elderly

2016
Show All
- Source
- Cite
- Save
Citations (0)
TRIMODALITY THERAPY FOR STAGE II-III CARCINOMA OF THE ESOPHAGUS: A DOSE-RANGING STUDY OF CONCURRENT CAPECITABINE, DOCETAXEL, AND THORACIC RADIOTHERAPY

2013 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (7)
First-line use of cabazitaxel in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (mCRPC): A three-arm study in comparison with docetaxel.

2012 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Docetaxel (DTX) and carboplatin (CP) followed by a dose-ranging study of oral capecitabine, weekly DTX, concomitant radiotherapy and surgery for the treatment of patients with stage II-III carcinoma of the esophagus

2004 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)